Product category:
Cell/tissue handling and counting
News Release from: Guava Technologies
Edited by the Laboratorytalk Editorial
Team on 11 August 2003
Micro-volume cell analysis to accelerate
research
Two organisations plan to explore new clinical applications for micro-volume benchtop cell analysis systems, and accelerate clinical research programmes
Guava Technologies and Partners HealthCare have formed a clinical research alliance The two organisations plan to explore new clinical applications for Guava's micro-volume benchtop cell analysis systems, as well as to use Guava's innovative tools to accelerate Partners's clinical research programmes
This article was originally published on Laboratorytalk on 23 Jun 2008 at 8.00am (UK)
Related stories
Simple detection of early and late apoptosis
The newly revised Guava Nexin Assay conveniently provides all necessary reagent components in a single cocktail to minimise assay steps, assay time and possible sources of contamination
CD4 monitoring for adult, paediatric measurements
Guava Technologies has announced a complete turnkey package for CD4 monitoring that requires minimum technical expertise to operate and obtain high quality results
Guava Technologies's personal cell analysis systems, the Guava PCA and Guava PCA-96, significantly simplify cell analysis and biological research by providing powerful, compact systems that scientists in the lab can use at their benchtop for a variety of testing purposes with less than a day of training.
Requiring only small numbers of cells in microlitre sample volumes, Guava's PCA systems produce highly accurate and easy-to-read results when researchers need them, thus streamlining the R and D process and markedly increasing research productivity.
"The ability to perform high-throughput experiments is key to the progress of our work," said Raju Kucherlapati, scientific director of the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics.
"Being able to perform micro-volume cell analysis assays in a 96-well format on our benchtops is highly beneficial to our research teams, as we can now conduct cell-based testing easily in our own labs.
"This gives us better control of our experiments and allows us to quickly make decisions and move to the next step in our research.
"Our alliance with Guava Technologies will increase both the speed and productivity of some of our key research programmes".
• Guava Technologies: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

